nautika1: targeted therapies in biomarker-selected stage ib-ii nsclc
Published 2 years ago • 167 plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
1:53
assessing targeted therapies in early stage nsclc
-
5:53
targeted therapy in non-small cell lung cancer
-
2:43
targeted therapy for early-stage lung cancer
-
2:20
selecting patients with nsclc who benefit from immunotherapy or targeted therapies
-
1:13
guiding nsclc treatment with biomarkers
-
1:38
moving forward: targeted therapies in early-stage lung cancer
-
1:09:51
lung cancer biomarkers & targeted therapies - webinar
-
0:55
challenges associated with biomarker testing for pd-l1 in nsclc
-
7:11
targeted therapy for alk-positive nsclc: a practical case study | biomarker-guided therapy in nsc...
-
0:52
genomic testing is necessary in non-small cell lung cancer
-
0:35
biomarkers and lung cancer
-
8:45
case 2: biomarkers and treatment decisions in stage iv nsclc
-
5:50
how is biomarker testing carried out?
-
5:51
nsclc biomarker testing in the uk
-
1:47
dr. bunn on tmb as a biomarker in small cell lung cancer
-
5:10
a patient’s perspective on biomarker testing in non-small cell lung cancer
-
2:09
biomarker guidelines for non-small cell lung cancer
-
6:04
genetic testing in non–small cell lung cancer
-
4:59
challenges in targeted drug development and treatment in lung cancer